Alnylam/Roche’s Zilebesiran Affirms Efficacy, But Commercially Relevant Data Await

 
• By Alaric DeArment
  
Alnylam announced results from the KARDIA-1 trial of zilebesiran • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D